VANCOUVER, BC — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on novel DNA-damage response technologies, announces the successful synthesis of novel small-molecule… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is pleased to report exciting… Read More
VANCOUVER, BC – Eyam Vaccines and Immunotherapeutics is rebranding to Eyam Health, effective January 2025. This change underscores the company’s broader mission to address global health challenges through innovative solutions… Read More
Topline data from the chronic cohort is expected in Q2 2025 Institutional Review Board (IRB) protocol amendment changes approved, and screening has been initiated for subacute cohort VANCOUVER, BC – NervGen Pharma… Read More
TORONTO, ON – HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX:HWAIF), a data science and AI company focused on preventative care, is pleased to announce that it has entered into… Read More
